Skip to content
Open in App
Alebund Pharmaceuticals

Alebund Pharmaceuticals

web2

Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops...

Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale

About

Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.

Expert Insight
Alebund Pharmaceuticals profile.

Expert Coverage

No published expert evaluations are available for this project yet.

PharmaceuticalsHealthcare
0team
0evaluations
0subscribers